Maraviroc intensification of cART in patients with suboptimal immunological recovery: a 48-week, placebo-controlled randomized trial

File: CD4 and CD8 subsets. This SPSS file contains the absolute number of CD4 and CD8 T cell subsets, as well as the percentage of CD31+ in CD4 naive T cells, at various time points during the MIRS trial. Please see the 'variable view' of the SPSS file and the 'methods' section of the paper for more information. We have used SAS software for our analyses.